Charles L. Cottriall

2.4k total citations · 1 hit paper
20 papers, 1.4k citations indexed

About

Charles L. Cottriall is a scholar working on Ophthalmology, Molecular Biology and Epidemiology. According to data from OpenAlex, Charles L. Cottriall has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Ophthalmology, 12 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Charles L. Cottriall's work include Glaucoma and retinal disorders (10 papers), Retinal Development and Disorders (8 papers) and Ophthalmology and Visual Impairment Studies (7 papers). Charles L. Cottriall is often cited by papers focused on Glaucoma and retinal disorders (10 papers), Retinal Development and Disorders (8 papers) and Ophthalmology and Visual Impairment Studies (7 papers). Charles L. Cottriall collaborates with scholars based in United Kingdom, Australia and Germany. Charles L. Cottriall's co-authors include Neville A. McBrien, Robert E. MacLaren, Susan M. Downes, Andrew Lotery, Miguel C. Seabra, Andrew R. Webster, Frans P.M. Cremers, Matthew J. During, Leonard W. Seymour and Tanya Tolmachova and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Ophthalmology.

In The Last Decade

Charles L. Cottriall

20 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial

2014 622 citations Robert E. MacLaren, Markus Groppe et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles L. Cottriall United Kingdom	16	803	658	425	352	319	20	1.4k
Jessica I. W. Morgan United States	20	902 1.1×	1.0k 1.6×	425 1.0×	298 0.8×	135 0.4×	49	1.5k
Ananth C. Viswanathan United Kingdom	19	1.5k 1.9×	1.3k 2.0×	596 1.4×	303 0.9×	334 1.0×	40	2.4k
Elizabeth A. M. Windsor United States	23	2.8k 3.4×	1.6k 2.5×	366 0.9×	140 0.4×	722 2.3×	28	2.9k
Mandeep S. Singh United States	25	1.6k 2.0×	1.0k 1.5×	577 1.4×	79 0.2×	684 2.1×	79	2.2k
Meike Visel United States	17	1.5k 1.9×	407 0.6×	184 0.4×	99 0.3×	558 1.7×	25	1.8k
Jasmina Cehajic‐Kapetanovic United Kingdom	19	794 1.0×	439 0.7×	219 0.5×	36 0.1×	377 1.2×	67	1.0k
Małgorzata Świder United States	27	2.4k 3.0×	1.6k 2.4×	478 1.1×	103 0.3×	530 1.7×	54	2.7k
Lu Yin United States	11	1.0k 1.3×	402 0.6×	163 0.4×	144 0.4×	282 0.9×	14	1.3k
Biju B. Thomas United States	24	1.4k 1.8×	438 0.7×	374 0.9×	27 0.1×	804 2.5×	80	1.8k
Markus Groppe United Kingdom	14	1.2k 1.5×	843 1.3×	350 0.8×	67 0.2×	123 0.4×	23	1.4k

Countries citing papers authored by Charles L. Cottriall

Since Specialization

Citations

This map shows the geographic impact of Charles L. Cottriall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles L. Cottriall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles L. Cottriall more than expected).

Fields of papers citing papers by Charles L. Cottriall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles L. Cottriall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles L. Cottriall. The network helps show where Charles L. Cottriall may publish in the future.

Co-authorship network of co-authors of Charles L. Cottriall

This figure shows the co-authorship network connecting the top 25 collaborators of Charles L. Cottriall. A scholar is included among the top collaborators of Charles L. Cottriall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles L. Cottriall. Charles L. Cottriall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cottriall, Charles L., Laura J. Taylor, Jasleen K. Jolly, et al.. (2023). Outcomes and Adverse Effects of Voretigene Neparvovec Treatment for Biallelic RPE65-Mediated Inherited Retinal Dystrophies in a Cohort of Patients from a Single Center. Biomolecules. 13(10). 1484–1484. 15 indexed citations

Cehajic‐Kapetanovic, Jasmina, Charles L. Cottriall, Jasleen K. Jolly, et al.. (2018). Electrophysiological verification of enhanced S-cone syndrome caused by a novel c.755T>C NR2E3 missense variant. Ophthalmic Genetics. 40(1). 29–33. 5 indexed citations

Edwards, Thomas L., Charles L. Cottriall, Kanmin Xue, et al.. (2017). Assessment of the Electronic Retinal Implant Alpha AMS in Restoring Vision to Blind Patients with End-Stage Retinitis Pigmentosa. Ophthalmology. 125(3). 432–443. 130 indexed citations

McKee, Justin, Charles L. Cottriall, John Elston, et al.. (2017). Amiloride does not protect retinal nerve fibre layer thickness in optic neuritis in a phase 2 randomised controlled trial. Multiple Sclerosis Journal. 25(2). 246–255. 15 indexed citations

Štingl, Katarína, Ruth Schippert, Karl Ulrich Bartz‐Schmidt, et al.. (2017). Interim Results of a Multicenter Trial with the New Electronic Subretinal Implant Alpha AMS in 15 Patients Blind from Inherited Retinal Degenerations. Frontiers in Neuroscience. 11. 445–445. 131 indexed citations

McKee, Justin, John Elston, Nikos Evangelou, et al.. (2016). Amiloride does not protect retinal nerve fibre layer thickness following acute optic neuritis; result from a phase II, double blind, randomised controlled trial.. Multiple Sclerosis Journal. 22. 21–22. 2 indexed citations

MacLaren, Robert E., Markus Groppe, Alun R. Barnard, et al.. (2014). Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial. The Lancet. 383(9923). 1129–1137. 622 indexed citations breakdown →

Wolffsohn, James S., et al.. (2014). An enhanced functional ability questionnaire (faVIQ) to measure the impact of rehabilitation services on the visually impaired.. SHILAP Revista de lepidopterología. 7(1). 77–85. 4 indexed citations

Morgan, Andrew, et al.. (2006). Prevalence Rate of Myopia in Schoolchildren in Rural Mongolia. Optometry and Vision Science. 83(1). 53–56. 27 indexed citations

10.

Cottriall, Charles L., et al.. (2002). Pirenzepine Affects Scleral Metabolic Changes in Myopia through a Non-toxic Mechanism. Experimental Eye Research. 74(1). 103–111. 28 indexed citations

11.

Vessey, Kirstan A., Charles L. Cottriall, & Neville A. McBrien. (2002). Muscarinic receptor protein expression in the ocular tissues of the chick during normal and myopic eye development. Developmental Brain Research. 135(1-2). 79–86. 17 indexed citations

12.

McBrien, Neville A., et al.. (2001). Retinal acetylcholine content in normal and myopic eyes: A role in ocular growth control?. Visual Neuroscience. 18(4). 571–580. 46 indexed citations

13.

Cottriall, Charles L., et al.. (2001). Inhibition of myopia development in chicks using himbacine: a role for M4 receptors?. Neuroreport. 12(11). 2453–2456. 31 indexed citations

14.

Cottriall, Charles L., J. O. Brew, Kirstan A. Vessey, & Neville A. McBrien. (2001). Diisopropylfluorophosphate alters retinal neurotransmitter levels and reduces experimentally-induced myopia. Naunyn-Schmiedeberg s Archives of Pharmacology. 364(4). 372–382. 24 indexed citations

15.

Cottriall, Charles L., et al.. (1999). Prevention of form‐deprivation myopia with pirenzepine: a study of drug delivery and distribution. Ophthalmic and Physiological Optics. 19(4). 327–335. 35 indexed citations

16.

Cottriall, Charles L.. (1999). Prevention of form-deprivation myopia with pirenzepine: a study of drug delivery and distribution. Ophthalmic and Physiological Optics. 19(4). 327–335. 14 indexed citations

17.

McBrien, Neville A., Alex Gentle, & Charles L. Cottriall. (1999). Optical Correction of Induced Axial Myopia in the Tree Shrew: Implications for Emmetropization. Optometry and Vision Science. 76(6). 419–427. 46 indexed citations

18.

Cottriall, Charles L. & Neville A. McBrien. (1996). The M1 muscarinic antagonist pirenzepine reduces myopia and eye enlargement in the tree shrew.. PubMed. 37(7). 1368–79. 85 indexed citations

19.

Cottriall, Charles L., et al.. (1995). Pirenzepine prevents form deprivation myopia in a dose dependent manner. Ophthalmic and Physiological Optics. 15(5). 351–356. 54 indexed citations

20.

McBrien, Neville A., et al.. (1995). The effects of blockade of retinal cell action potentials on ocular growth, emmetropization and form deprivation myopia in young chicks. Vision Research. 35(9). 1141–1152. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact